Loestrin Buyers' Attys Seek $43M From Antitrust Deal
By Anne Cullen ( April 21, 2020, 6:12 PM EDT) -- The legal team that helped direct buyers of birth control Loestrin snag a $120 million deal with drugmakers Warner Chilcott and Watson Pharmaceuticals over antitrust and fraud allegations is seeking just under $43 million of the pot to cover fees and expenses....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.